|
 |
| LETTER TO THE EDITOR |
|
| Year : 2021 | Volume
: 69
| Issue : 4 | Page : 1002-1004 |
|
COVID-19 and orbital mucormycosis
Sandip Sarkar1, Tanmay Gokhale1, Sushmita Sana Choudhury2, Amit Kumar Deb1
1 Department of Ophthalmology, Jawaharlal Institute of Post Graduate Medical Education and Research, Puducherry, India
2 Department of Microbiology, Jawaharlal Institute of Post Graduate Medical Education and Research, Karaikal, India
| Date of Web Publication | 16-Mar-2021 |
Correspondence Address:
Dr. Amit Kumar Deb
Department of Ophthalmology, Jawaharlal Institute of Post Graduate Medical Education and Research, Gorimedu, Puducherry - 605 006
India
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/ijo.IJO_3763_20
How to cite this article:
Sarkar S, Gokhale T, Choudhury SS, Deb AK. COVID-19 and orbital mucormycosis. Indian J Ophthalmol 2021;69:1002-4 |
Dear Editor,
The 2019 novel coronavirus (2019-nCoV) or severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) first reported in Wuhan, Hubei province in China, quickly spread to other parts of the world forming a global pandemic.[1] The disease pattern of COVID-19 can range from mild to life-threatening pneumonia with associated bacterial and fungal coinfections.[2] Due to the associated comorbidities (e.g., diabetes mellitus, chronic obstructive pulmonary disease) and immunocompromised conditions (e.g. corticosteroid therapy, ventilation, intensive care unit stay), these patients are prone to develop severe opportunistic infections. There are reports of the development of severe opportunistic infections such as oropharyngeal candidiasis, pneumocystis jiroveci pneumonia, pulmonary aspergillosis, bloodstream candida infections, etc., in patients affected with COVID-19 disease.[3],[4] There are also few isolated case reports of rhino-orbital mucormycosis in COVID-19 disease.[2],[5] Sen et al. recently reported a series of six cases of COVID-19 disease with rhino-orbital mucormycosis. One patient in this series had concurrent COVID-19 and mucormycosis at admission, while five other patients developed mucormycosis during treatment with systemic steroids for COVID-19.[6] We, hereby, report a cluster of 10 cases of clinically diagnosed orbital mucormycosis with concurrent COVID-19 illness at our institute over the last 2 months (October and November 2020). They presented to us with clinical features of orbital mucormycosis and COVID-19 was diagnosed on routine screening. Demographic and clinical profiles of the patients are provided in [Table 1]. Microbiological and radiological diagnosis along with treatment received and final outcome are provided in [Table 2]. Potassium hydroxide (KOH) wet mount and fungal culture/sensitivity were done from biopsy obtained during debridement or from nasal swab obtained during diagnostic nasal endoscopy. Microbiological diagnosis of mucormycosis was proven in six patients. Reverse transcriptase-polymerase chain reaction (RT-PCR) tests for COVID-19 were positive in all the patients. All patients in our series were known diabetics. Diabetic ketoacidosis (DKA) was evident in four patients during admission while five more patients developed DKA after the initiation of corticosteroid therapy for COVID-19 disease. All patients in our series had received intravenous dexamethasone for COVID-19 disease as per The National Institute of Health recommendations[7] and Liposomal Amphotericin B for mucormycosis. Besides, four patients received an injection of Remdesivir, and nine patients required ventilatory support during their hospital stay. The use of steroids, monoclonal antibodies, and broad-spectrum antibiotics for the management of COVID-19 illness can increase the chances of new-onset fungal infection or exacerbate a preexisting one.[2] All patients in our series had received intravenous dexamethasone for COVID-19 disease and Liposomal Amphotericin B for mucormycosis. Four patients in our series expired within 1 month of the diagnosis, five patients had satisfactory systemic outcomes, but with irreversible vision loss, while only one patient had both ocular and systemic favorable outcomes. | Table 2: Radiological and microbiological diagnosis, treatment, and final outcome of the patients
Click here to view |
COVID-19 disease has a propensity to cause extensive pulmonary disease and subsequent alveolo-interstitial pathology. This by itself may predispose to invasive fungal infections of the airways including the sinuses and the lungs.[2],[8] Furthermore, there is an alteration of the innate immunity due to COVID-19-associated immune dysregulation characterized by decreased T cells, including CD4 and CD8 cells.[2],[6] All physicians including ophthalmologists should, therefore, be mindful of the probability of development of fungal infections such as mucormycosis in patients with COVID-19 illness, especially in those with comorbidities and on immunosuppressive agents in the coming future.[6]
Financial support and sponsorship
Nil.
Conflicts of interest
There are no conflicts of interest.
| References | |  |
| 1. | Farnoosh G, Alishiri G, Hosseini Zijoud SR, Dorostkar R, Jalali Farahani A. Understanding the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease (COVID-19) based on available evidence-A narrative review. J Mil Med 2020;22:1-11.  |
| 2. | Mehta S, Pandey A. Rhino-orbital mucormycosis associated with COVID-19. Cureus 2020;12:e10726. |
| 3. | Salehi M, Ahmadikia K, Badali H, Khodavaisy S. Opportunistic fungal infections in the epidemic area of COVID-19: A clinical and diagnostic perspective from Iran. Mycopathologia 2020;185:607-11. |
| 4. | Chowdhary A, Tarai B, Singh A, Sharma A. Multidrug-resistant Candida auris infections in critically Ill coronavirus disease patients, India, April–July 2020. Emerg Infect Dis 2020;26:2694-6. |
| 5. | Mekonnen ZK, Ashraf DC, Jankowski T, Grob SR, Vagefi MR, Kersten RC, et al. Acute invasive rhino-orbital mucormycosis in a patient with COVID-19-associated acute respiratory distress syndrome. Ophthalmic Plast Reconstr Surg 2020. doi: 10.1097/IOP. 0000000000001889. |
| 6. | Sen M, Lahane S, Lahane TP, Parekh R, Honavar SG. Mucor in a viral land: A tale of two pathogens. Indian J Ophthalmol 2021;69:244-52. [ PUBMED] [Full text] |
| 7. | COVID-19 Treatment Guidelines Panel. Coronavirus disease 2019 (COVID-19) treatment guidelines. National Institutes of Health. 2020. [Last accessed on 2020 Dec 23]. |
| 8. | Gangneux JP, Bougnoux ME, Dannaoui E, Cornet M, Zahar JR. Invasive fungal diseases during COVID-19: We should be prepared. J Mycol Med 2020;30:100971. doi: 10.1016/j.mycmed.2020.100971. |
[Table 1], [Table 2]
| This article has been cited by | | 1 |
Surge of mucormycosis during the COVID-19 pandemic |
|
| Paulami Dam, Marlon H. Cardoso, Sukhendu Mandal, Octávio L. Franco, Pinar Sagiroglu, Osman Ahmet Polat, Kerem Kokoglu, Rittick Mondal, Amit Kumar Mandal, Ismail Ocsoy | | Travel Medicine and Infectious Disease. 2023; 52: 102557 | | [Pubmed] | [DOI] | | | 2 |
Imaging Features of COVID-19-Associated Acute Invasive Fungal Rhinosinusitis |
|
| Nishtha Yadav, Ambuj Kumar, Kavita Sachdeva, Shruti Asati | | Indian Journal of Neurosurgery. 2023; | | [Pubmed] | [DOI] | | | 3 |
Hit or Miss: The Dilemma of Specimen Selection for Microbiological
Diagnosis of Rhino-Orbital-Cerebral- COVID-Associated Mucormycosis
(ROCM-CAM) |
|
| Vidhi Jain, Alisha Aggarwal, Twishi Shrimali, Kirti Vishwakarma, Debaleena Paul, Sarika Prabhakar Kombade, Vidhu Sharma, Kapil Soni, Bikram Choudhary, Amit Goyal, Ankita Chugh, Sarbesh Tiwari, Deepak Kumar Sharma, Ashwini Agarwal, Sanjeev Misra | | Infectious Disorders - Drug Targets. 2023; 23(1) | | [Pubmed] | [DOI] | | | 4 |
Mucormycosis in patients with COVID-19 in Russia: the results of a prospective multi-center study |
|
| S. N. Khostelidi, V. A. Zaytsev, S. A. Vartanyan, N. A. Nikitin, G. N. Evtukh, M. N. Gilalov, G. V. Portnov, A. A. Zubareva, I. B. Baranova, T. S. Bogomolova, Yu. L. Avdeenko, O. V. Shadrivova, E. A. Desyatik, E. V. Shagdileeva, Yu. V. Borzova, Yu. A. Krivolapov, N. V. Vasilyeva, N. N. Klimko | | Journal Infectology. 2022; 14(2): 116 | | [Pubmed] | [DOI] | | | 5 |
Clinicoradiological profile and outcome of cavernous sinus syndrome with coronavirus disease-2019-associated rhino-orbito-cerebral mucormycosis |
|
| Sulena Sulena, Munish Dhawan, Navchint Singh, Hobinder Arora, Gurbax Singh, Varun Aggarwal, Chaitanya Tapasvi | | Journal of Neurosciences in Rural Practice. 2022; 0: 1 | | [Pubmed] | [DOI] | | | 6 |
Rhino-orbital mucormycosis in a patient with no susceptibility following P.vivax malaria infection—a case report |
|
| Sonali Prasad, Aman Gaur, Anuj Mehta, Nimisha Kaushal | | BMC Ophthalmology. 2022; 22(1) | | [Pubmed] | [DOI] | | | 7 |
Posterior segment findings in post-Covid mucormycosis: A cross-sectional study |
|
| Zainu Shams, C Shwetha Kumari, Malvika S B Mutt, Bharathi N, Madhura M Khanapur | | IP International Journal of Ocular Oncology and Oculoplasty. 2022; 8(2): 136 | | [Pubmed] | [DOI] | | | 8 |
The Pathogenetic Dilemma of Post-COVID-19 Mucormycosis in India |
|
| Sankha Shubhra Chakrabarti, Upinder Kaur, Sushil Kumar Aggarwal, Ahalya Kanakan, Adesh Saini, Bimal Kumar Agrawal, Kunlin Jin, Sasanka Chakrabarti | | Aging and disease. 2022; 13(1): 24 | | [Pubmed] | [DOI] | | | 9 |
Diagnosis of invasive Mucormycosis on Histopathological examination at a tertiary referral hospital |
|
| Pavani Marapaka, Laxmi Pravalika | | IP Archives of Cytology and Histopathology Research. 2022; 7(2): 85 | | [Pubmed] | [DOI] | | | 10 |
Perioperative management of patients with post Covid rhino-orbito-cerebral mucormycosis: Prospective observational study |
|
| Bhoomika Kalarthi, Devyani Desai, Neha Shah, Neha Cheraya, Sagar Bavisetti, Parvathy D, Abhishek Zala, Kanchan Choube, Gaurav Cheraya | | Indian Journal of Clinical Anaesthesia. 2022; 9(2): 214 | | [Pubmed] | [DOI] | | | 11 |
An observational study of treatment and outcomes of patients admitted in a dedicated Covid hospital in central India during second wave of Covid -19 pandemic |
|
| Kavita M. Jaiswal, Sujata Dudhgaonkar, Ramesh Sugandh, Kalpana V Jaiswal, Latesh Raghute | | IP International Journal of Comprehensive and Advanced Pharmacology. 2022; 7(3): 151 | | [Pubmed] | [DOI] | | | 12 |
Rhinoorbital mucormycosis in COVID-19 pandemic: presentation and course of disease: An observational study |
|
| Maya Sharma, Seema Rajvanshi, Sunita Khurana, Rajkumar Arora | | Indian Journal of Clinical and Experimental Ophthalmology. 2022; 7(4): 624 | | [Pubmed] | [DOI] | | | 13 |
Effects of SARS-Cov-2 infection and rhino-orbital mucormycosis on concentrations of inflammatory biomarkers in Indian populations |
|
| Rajendra Prakash Maurya, Ajay Kumar Yadav, Shivam Tiwari, Bhupendra Kumar, Abhay Kumar Yadav, Ashish Ashish, Nitish Kumar Singh, Manpreet Kaur, Shivani Mishra, Shani Vishwakarma, Surendra Pratap Mishra, Nargis Khanam, Pooja Dubey, Janhavi Yadav, Royana Singh | | Indian Journal of Clinical and Experimental Ophthalmology. 2022; 8(4): 450 | | [Pubmed] | [DOI] | | | 14 |
Analysis of ophthalmic manifestations of invasive rhino-orbito-cerebral mucormycosis in COVID-19 patients in a medical college |
|
| Priyanka Patel, Yamini Rawate | | Indian Journal of Clinical and Experimental Ophthalmology. 2022; 8(4): 481 | | [Pubmed] | [DOI] | | | 15 |
A fungal epidemic amidst a viral pandemic: Risk factors for development of COVID-19 associated rhino-orbital-cerebral mucormycosis in India |
|
| Varshitha Hemanth Vasanthapuram, Roshmi Gupta, Namrata Adulkar, Akshay Gopinathan Nair, Renuka A Bradoo, Raghuraj Hegde, Usha Singh, Sameeksha Tadepalli, Bipasha Mukherjee, Saurabh Kamal, Md Shahid Alam, Raksha Rao, Sushma Ananthakrishna, Varsha Backiavathy, Ajay Krishna Murthy, Lynn D’Cunha, Gagan Dudeja, Annie Joji, Anjali Kiran, Kirti Koka, Moupia Goswami Mukhopadhyay, Sonam Poonam Nisar, Priyanka R. Rao, Chhaya A. Shinde | | Orbit. 2022; : 1 | | [Pubmed] | [DOI] | | | 16 |
MRI as a road map for surgical intervention of acute invasive fungal sinusitis in Covid-19 era |
|
| Ahmed Hassan Sweed, Mohamed Mobashir, Ismail Elnashar, Ahmed Anany, Mohammed Elsayed Elmaghawry, Enas Moustafa Ibrahim, Mohamed Eesa | | Clinical Otolaryngology. 2022; | | [Pubmed] | [DOI] | | | 17 |
Sensitivity of liquid-based cytology in the diagnosis of mucormycosis in
COVID
-19 treated patients
|
|
| Rabish Kumar, Meeta Singh, Tanu Sagar, Bharanidharan, Nita Khurana, Vikas Kumar, Ravi Meher, Vikas Malhotra, Ruchi Goel, Sonal Saxena, Jyoti Kumar | | Cytopathology. 2022; | | [Pubmed] | [DOI] | | | 18 |
COVID-19-associated acute invasive fungal sinusitis: Clinical and imaging findings |
|
| Ali H. Elmokadem, Dalia Bayoumi, Manar Mansour, Mahitab Ghonim, Eman A. Saad, Doaa Khedr | | Journal of Neuroimaging. 2022; | | [Pubmed] | [DOI] | | | 19 |
Epidemiology, clinical presentation and management of COVID-19 associated mucormycosis: A single centre experience from Pune, Western India |
|
| Ameet Dravid, Reema Kashiva, Zafer Khan, Balasaheb Bande, Danish Memon, Aparna Kodre, Milind Mane, Vishal Pawar, Dattatraya Patil, Suraj Kalyani, Prathamesh Raut, Madhura Bapte, Charlotte Saldanha, Dinesh Chandak, Teerthagouda Patil, Sateesh Reddy, Krushnadas Bhayani, Laxmi Suresh, Vishnu Dillibabu, Shipra Srivastava, Shubham Khandelwal, Sailee More, Atif Shakeel, Mohit Pawar, Pranava Nande, Amol Harshe, Sagar Kadam, Sudhir Hallikar, Nudrat Kamal, Danish Andrabi, Sachin Bodhale, Akshay Raut, Sangeeta Chandrashekhar, Chandrashekhar Raman, Uma Mahajan, Gaurav Joshi, Dilip Mane | | Mycoses. 2022; | | [Pubmed] | [DOI] | | | 20 |
Experience on rhino-orbital mucormycosis from a tertiary care hospital in the first wave of COVID-19: An Indian perspective |
|
| Gunjan Saluja, Anju Bhari, Neelam Pushker, Sahil Agrawal, Rachna Meel, Alok Thakar, Immaculata Xess, Ankur Khandelwal, Anubhav Narwal, Mandeep S. Bajaj | | Medical Journal Armed Forces India. 2022; | | [Pubmed] | [DOI] | | | 21 |
Mucormycosis (black fungus) ensuing COVID-19 and comorbidity meets - Magnifying global pandemic grieve and catastrophe begins |
|
| Karthika Pushparaj, Haripriya Kuchi Bhotla, Vijaya Anand Arumugam, Manikantan Pappusamy, Murugesh Easwaran, Wen-Chao Liu, Utthapon Issara, Kannan R.R. Rengasamy, Arun Meyyazhagan, Balamuralikrishnan Balasubramanian | | Science of The Total Environment. 2022; 805: 150355 | | [Pubmed] | [DOI] | | | 22 |
Manifestations of Mucormycosis and Its Complications in COVID-19 Patients: A Case Series Study |
|
| Mohammadsmaeil Kordjazi, Narges Bazgir, Kourosh Eftekharian, Mostafa Farajpour, Nader Akbari Dilmaghani | | Ear, Nose & Throat Journal. 2022; : 0145561322 | | [Pubmed] | [DOI] | | | 23 |
Coronavirus Disease 2019 (COVID-19)–Associated Rhino-Orbito-Cerebral Mucormycosis: A Multi-Institutional Retrospective Study of Imaging Patterns |
|
| Sharath Kumar GG, Saikant Deepalam, Ata Siddiqui, Chaitra P. Adiga, Savith Kumar, Shivakumar Swamy Shivalingappa, Ullas V. Acharya, Lakshmikanth N. Goolahally, Saksham Sharma, Dhilip Andrew, Pradeep Hosmani, Satish Nair, Gaurav Medikeri, Ravi Mohan Rao, Jagadish B. Agadi, Sujit Kumar, Gurucharan Adoor, Suryanarayana Sharma, Raghuraj Hegde, Jitender Saini, Karthik Kulanthaivelu | | World Neurosurgery. 2022; | | [Pubmed] | [DOI] | | | 24 |
The emergence of COVID-19 associated mucormycosis: a review of cases from 18 countries |
|
| Martin Hoenigl, Danila Seidel, Agostinho Carvalho, Shivaprakash M Rudramurthy, Amir Arastehfar, Jean-Pierre Gangneux, Nosheen Nasir, Alexandro Bonifaz, Javier Araiza, Nikolai Klimko, Alexandra Serris, Katrien Lagrou, Jacques F Meis, Oliver A Cornely, John R Perfect, P Lewis White, Arunaloke Chakrabarti | | The Lancet Microbe. 2022; | | [Pubmed] | [DOI] | | | 25 |
An insight into SARS-CoV-2 structure, pathogenesis, target hunting for drug development and vaccine initiatives |
|
| Arijit Ghosh, Paritosh K. Kar, Anupam Gautam, Rahul Gupta, Rajveer Singh, Rudra Chakravarti, Velayutham Ravichandiran, Shubhra Ghosh Dastidar, Dipanjan Ghosh, Syamal Roy | | RSC Medicinal Chemistry. 2022; | | [Pubmed] | [DOI] | | | 26 |
COVID-19 Associated Mucormycosis with Newly Diagnosed Diabetes Mellitus in Young Males – A Tertiary Care Experience |
|
| Sahil Kapoor, Poonam Kumar Saidha, Ayushi Gupta, Urvi Saini, Sneha Satya | | International Archives of Otorhinolaryngology. 2022; 26(03): e470 | | [Pubmed] | [DOI] | | | 27 |
Onset of Mucormycosis in Patients with COVID-19: A Systematic Review on Patients' Characteristics |
|
| Shohreh Ghasemi, Mahmood Dashti, Amir Fahimipour, Ghazaleh Daryakenari, Fatemeh Mirzaei, Fatemeh Akbari, Zohaib Khurshid | | European Journal of Dentistry. 2022; | | [Pubmed] | [DOI] | | | 28 |
Endovascular Infusion of Amphotericin B for the Treatment of Rhino-Orbito-Cerebral Mucormycosis: A Pilot Study Assessing Technical Feasibility and Safety |
|
| Subhash Kumar, Kranti Bhavana, Vijay Kumar, Amarjeet Kumar, Mala Mahto | | The Arab Journal of Interventional Radiology. 2022; | | [Pubmed] | [DOI] | | | 29 |
Demographic and Clinical Profile of Patients Presenting with COVID-19-Associated Rhino-orbito-cerebral Mucormycosis at a Tertiary Care Center |
|
| Siddharth Madan, Rekha Yadav, Jolly Rohatgi, Rahul Sharma, Iffat Nasir, Aarushi Saini, Nampi Tadu, Gopal Krushna Das, Pramod Kumar Sahu, Neelima Gupta, Nitika Beri | | Annals of the National Academy of Medical Sciences (India). 2022; | | [Pubmed] | [DOI] | | | 30 |
Mucormycosis and COVID-19 pandemic: Clinical and diagnostic approach |
|
| Asim Azhar, Wajihul Hasan Khan, Parvez Anwar Khan, Khaled Al-hosaini, Mohammad Owais, Aijaz Ahmad | | Journal of Infection and Public Health. 2022; | | [Pubmed] | [DOI] | | | 31 |
Mucormycosis an added burden to Covid-19 Patients: An in-depth Systematic Review |
|
| Naveed Nazir Shah, Zaid Khan, Hashim Ahad, Abozer Y Elderdery, Mohammad N. Alomary, Banan Atwah, Zain Alhindi, Mahdi H Alsugoor, Ahmed ME Elkhalifa, Showket Nabi, Showkeen Muzamil Bashir, Tahir Yaqub, Gulzar Ahmed Rather, Mohammad Azam Ansari | | Journal of Infection and Public Health. 2022; | | [Pubmed] | [DOI] | | | 32 |
COVID-19 associated mucormycosis – An emerging threat |
|
| Chien-Ming Chao, Chih-Cheng Lai, Wen-Liang Yu | | Journal of Microbiology, Immunology and Infection. 2022; | | [Pubmed] | [DOI] | | | 33 |
An overview of COVID-19 related to fungal infections: what do we know after the first year of pandemic? |
|
| R. G. Vitale, J. Afeltra, S. Seyedmousavi, S. L. Giudicessi, S. M. Romero | | Brazilian Journal of Microbiology. 2022; | | [Pubmed] | [DOI] | | | 34 |
COVID-19 and ocular complications: A review of ocular manifestations, diagnostic tools, and prevention strategies |
|
| Jilian Dong, Ruida Chen, Hanhe Zhao, Yirui Zhu | | Advances in Ophthalmology Practice and Research. 2022; | | [Pubmed] | [DOI] | | | 35 |
COVID-19 and Fungal Infections: A Double Debacle |
|
| Sara Mina, Hajar Yaakoub, Cédric Annweiler, Vincent Dubée, Nicolas Papon | | Microbes and Infection. 2022; : 105039 | | [Pubmed] | [DOI] | | | 36 |
Mucormycosis infection in patients with
COVID
-19: A systematic review
|
|
| SeyedAhmad SeyedAlinaghi, Amirali Karimi, Alireza Barzegary, Zahra Pashaei, Amir Masoud Afsahi, Sanam Alilou, Nazanin Janfaza, Alireza Shojaei, Fatemeh Afroughi, Parsa Mohammadi, Yasna Soleimani, Newsha Nazarian, Ava Amiri, Marcarious M. Tantuoyir, Shahram Oliaei, Esmaeil Mehraeen, Omid Dadras | | Health Science Reports. 2022; 5(2) | | [Pubmed] | [DOI] | | | 37 |
Mucormycosis in COVID-19 pandemic: study at tertiary hospital in India |
|
| Reshma P. Chavan, Shivraj M. Ingole, Hamna Abdul Nazir, Wilson V. Desai, Gajanan S. Kanchewad | | European Archives of Oto-Rhino-Laryngology. 2022; | | [Pubmed] | [DOI] | | | 38 |
Risk Factors of COVID-19 Associated Mucormycosis (CAM) in Iranian Patients: A Single-Center Retrospective Study |
|
| Soheil Tavakolpour, Shirin Irani, Mir Saeed Yekaninejad, Masoud Alimardi, Mehrdad Hasibi, Hamed Abdollahi, Mohammad Ali Kazemi, Maryam Lotfi, Haneyeh Shahbazian, Nader Ali Nazemian Yazdi, Seyedhadi Samimiardestani, Mohammadreza Firouzifar, Farbod Farahbakhsh, Mohammadreza Mirzaee Goodarzi, Firoozeh Feiz, Farahnaz Salehinia | | Mycopathologia. 2022; | | [Pubmed] | [DOI] | | | 39 |
The impact of mucormycosis (black fungus) on SARS-CoV-2-infected patients: at a glance |
|
| Md. Rezaul Islam, Md. Mominur Rahman, Md. Tanjimul Ahasan, Nadia Sarkar, Shopnil Akash, Mahfuzul Islam, Fahadul Islam, Most. Nazmin Aktar, Mohd Saeed, Md. Harun-Or-Rashid, Md. Kawsar Hosain, Md. Saidur Rahaman, Sadia Afroz, Shabana Bibi, Md. Habibur Rahman, Sherouk Hussein Sweilam | | Environmental Science and Pollution Research. 2022; | | [Pubmed] | [DOI] | | | 40 |
Retrobulbar Amphotericin B Injection in Curbing the Progression of COVID Associated Rhino-orbital Cerebral Mucormycosis: A Retrospective Case Series |
|
| Madhumallika Pathak, Vijaya Sahu, Ripu Daman Arora, Martina M. Shambharkar, Prithvi Naveen, Saroj Kumar Pati, Nitin M. Nagarkar | | Indian Journal of Otolaryngology and Head & Neck Surgery. 2022; | | [Pubmed] | [DOI] | | | 41 |
Mucormycosis: risk factors, diagnosis, treatments, and challenges during COVID-19 pandemic |
|
| Ayushi Sharma, Anjana Goel | | Folia Microbiologica. 2022; | | [Pubmed] | [DOI] | | | 42 |
Mortality-Related Risk Factors for Coronavirus Disease (COVID-19)-Associated Mucormycosis: a systematic review and meta-analysis |
|
| Vahid Reza Ostovan, Reza Tabrizi, Hanieh Bazrafshan, Zahra Bahrami, Hajar Khazraei, Samaneh Khazraei, Afshin Borhani-Haghighi, Mohsen Moghadami, Matthew Grant | | Current Fungal Infection Reports. 2022; | | [Pubmed] | [DOI] | | | 43 |
Mucormycosis: A new threat to Coronavirus disease 2019 with special emphasis on India |
|
| Deganta Ghosh, Sagardeep Dey, Himanko Chakraborty, Sneha Mukherjee, Ankita Halder, Akash Sarkar, Pallab Chakraborty, Rajdeep Ghosh, Joy Sarkar | | Clinical Epidemiology and Global Health. 2022; 15: 101013 | | [Pubmed] | [DOI] | | | 44 |
The role of SARS-CoV-2 immunosuppression and the therapy used to manage COVID-19 disease in the emergence of opportunistic fungal infections: A review |
|
| Nahid Akhtar, Atif Khurshid Wani, Surya Kant Tripathi, Ajit Prakash, M. Amin-ul Mannan | | Current Research in Biotechnology. 2022; | | [Pubmed] | [DOI] | | | 45 |
Update on overview of ocular manifestations of COVID-19 |
|
| Mitra Akbari, Maryam Dourandeesh | | Frontiers in Medicine. 2022; 9 | | [Pubmed] | [DOI] | | | 46 |
Antifungal Effect of Nanoparticles against COVID-19 Linked Black Fungus: A Perspective on Biomedical Applications |
|
| Sangiliyandi Gurunathan, Ah Reum Lee, Jin Hoi Kim | | International Journal of Molecular Sciences. 2022; 23(20): 12526 | | [Pubmed] | [DOI] | | | 47 |
Fungal Infections Other Than Invasive Aspergillosis in COVID-19 Patients |
|
| Kerri Basile, Catriona Halliday, Jen Kok, Sharon C-A. Chen | | Journal of Fungi. 2022; 8(1): 58 | | [Pubmed] | [DOI] | | | 48 |
Diagnostic Performance and Clinical Utility of Conventional PCR Assay in Early Diagnosis of COVID-19 Associated Rhino-Orbito-Cerebral Mucormycosis |
|
| Samir Mohapatra, Manas Ranjan Barik, Suryasnata Rath, Savitri Sharma, Archisman Mohapatra, Sharmistha Behera, Souvagini Acharya, Dipti Ranjan Pattjoshi, Rajesh Kumar Padhi, Himansu Sekhar Behera | | Journal of Fungi. 2022; 8(8): 844 | | [Pubmed] | [DOI] | | | 49 |
SARS-CoV-2 in Kidney Transplant Recipients: A Systematic Review |
|
| Naveen Kumar, Rashmi Rana, Devinder Singh Rana, Anurag Gupta, Mohinder Pal Sachdeva | | Transplantology. 2022; 3(1): 33 | | [Pubmed] | [DOI] | | | 50 |
COVID-19-Associated Mucormycosis: A Matter of Concern Amid the SARS-CoV-2 Pandemic |
|
| Pankaj Chandley, Priyanka Subba, Soma Rohatgi | | Vaccines. 2022; 10(8): 1266 | | [Pubmed] | [DOI] | | | 51 |
IMAGING OF RHINO-ORBITO-CEREBRAL MUCORMYCOSIS A PROSPECTIVE OBSERVATIONAL STUDY IN THE SETTING OF COVID 19 PANDEMIC IN A TERTIARYCARE CENTRE IN AP, INDIA |
|
| P. Sathishkumar, K. Sindhura, Bomidi Sudha Rani, P. Bujjibabu | | INTERNATIONAL JOURNAL OF SCIENTIFIC RESEARCH. 2022; : 36 | | [Pubmed] | [DOI] | | | 52 |
RELATIONSHIP OF HYPOALBMINEMIA WITH OUTCOME OF RHINO-ORBITO-CEREBRAL MUCORMYCOSIS (ROCM), A TERTIARY CARE CENTER BASED STUDY. |
|
| Shyamash Mandal, Souvik Das, Abhisek Mallik, Syamal Kundu | | PARIPEX INDIAN JOURNAL OF RESEARCH. 2022; : 29 | | [Pubmed] | [DOI] | | | 53 |
Orbital Complications of Acute Invasive Fungal Rhinosinusitis: A New Challenge in the COVID-19 Convalescent Patients |
|
| Dina Tadros, Mohamed O Tomoum, Heba M Shafik | | Clinical Ophthalmology. 2022; Volume 16: 4011 | | [Pubmed] | [DOI] | | | 54 |
Study of Molds in Post COVID -19 Patients: An experience from Tertiary Care Centre |
|
| Neeta Gade | | Journal of Infectious Diseases & Microbiology. 2022; | | [Pubmed] | [DOI] | | | 55 |
Mucormycosis in patients with COVID-19: A descriptive study at a tertiary care hospital in North Maharashtra |
|
| GaneshShrihari Lokhande, YogitaGopal Bavaskar, VilasRaghunath Malkar, Jaiprakash Ramanand, JitendraBhaskar Surwade, DanielArun Saji, Sandeep Suryawanshi | | MGM Journal of Medical Sciences. 2022; 9(1): 72 | | [Pubmed] | [DOI] | | | 56 |
Mucormycosis in Post-COVID Patients: A Review |
|
| K Manimekalai, JV Sabarianandh, Packia Sakaya Mercy, L Bernaitis, L Benita Mary | | SBV Journal of Basic, Clinical and Applied Health Science. 2022; 5(2): 34 | | [Pubmed] | [DOI] | | | 57 |
Rhino-orbital-cerebral mucormycosis as a complication of coronavirus disease 2019 |
|
| Raid M Al-Ani | | World Journal of Virology. 2022; 11(5): 293 | | [Pubmed] | [DOI] | | | 58 |
Study of Profile of Mucormycosis During the Second Wave of COVID-19 in a Tertiary Care Hospital |
|
| Sangita Kamath, Manish Kumar, Nilanjan Sarkar, Tauheed Ahmed, Ashok Sunder | | Cureus. 2022; | | [Pubmed] | [DOI] | | | 59 |
Clinicopathological Study of Mucormycosis in COVID-19 Patients: Experience From a Tertiary Care Center in South India |
|
| Sangeetha Kandasamy, Srinivas Muthuraju, Arumugam Vasugi, Megala Chandrasekar, Roopmala Murugan, Poovizhi Inbasekaran, Prabu R | | Cureus. 2022; | | [Pubmed] | [DOI] | | | 60 |
Outcomes of Transcutaneous Retrobulbar Amphotericin B in Rhino-Orbital-Cerebral Mucormycosis Among Patients Recovering From COVID-19: A Preliminary Experience |
|
| Shivani Sinha, Vidya B Kumar, Abhay Kumar, Vivek Singh, Abhishek Anand, Rakhi Kusumesh, Sarita Mishra, Pragati Raj, Bibhuti P Sinha | | Cureus. 2022; | | [Pubmed] | [DOI] | | | 61 |
Clinical Profile of Patients Admitted With Mucormycosis During the COVID-19 Pandemic in Medicine Emergency of a Tertiary Care Hospital in North India |
|
| Neeraj Singla, Nalin Sharma, Navneet Sharma, Ashish Behera, Mandip Bhatia | | Cureus. 2022; | | [Pubmed] | [DOI] | | | 62 |
Fatality Chooses Its Path Through the Orbit: A Study of Rhino-Orbito-Cerebral Mucormycosis as a Complication of COVID-19 Infection |
|
| Samreen Mehfooz, Neelima Mehrotra, Tarim Usmani, Vivek Raj | | Cureus. 2022; | | [Pubmed] | [DOI] | | | 63 |
Coronavirus Disease-Associated Mucormycosis from a Tertiary Care Hospital in India: A Case Series |
|
| Yudhyavir Singh, Venkata Ganesh, Shailendra Kumar, Nishant Patel, Richa Aggarwala, Kapil Dev Soni, Anjan Trikha | | Cureus. 2021; | | [Pubmed] | [DOI] | | | 64 |
A Retrospective Analysis of Risk Factors of COVID-19 Associated Mucormycosis and Mortality Predictors: A Single-Center Study |
|
| Kapil Zirpe, Prajakta Pote, Abhijit Deshmukh, Sushma K Gurav, Anand M Tiwari, Prasad Suryawanshi | | Cureus. 2021; | | [Pubmed] | [DOI] | | | 65 |
Optic neuritis in post-Covid rhino-orbito-cerebral mucormycosis (ROCM): A rare presentation |
|
| Parul Singh, Perwez Khan, Anshika Gupta, Namrata Patel, Tejasvini Chandra, Dinesh Kumar Yadav | | International Journal of Case Reports and Images. 2021; 12: 1 | | [Pubmed] | [DOI] | | | 66 |
Mucormycosis in COVID Diabetic Patients: A Horrifying Triad! |
|
| Amit Kumar, Bhavna Gupta, Anish Gupta, Parshika Panwar, Shiv C Navriya | | Indian Journal of Critical Care Medicine. 2021; 25(11): 1314 | | [Pubmed] | [DOI] | | | 67 |
Emerging cases of mucormycosis under
COVID
-19 pandemic in India: Misuse of antibiotics
|
|
| Gaurav Gupta, Roshan S., Yogendra Singh, Lakshmi Thangavelu, Sachin Kumar Singh, Harish Dureja, Dinesh Kumar Chellappan, Kamal Dua | | Drug Development Research. 2021; 82(7): 880 | | [Pubmed] | [DOI] | | | 68 |
Mucormycosis following COVID19: clinical case and literature review |
|
| Sofya N. Khostelidi, V.A. Zaytsev, E.V. Pelikh, E.V. Yashina, O.N. Rodionova, T.S. Bogomolova, Yu.L. Avdeenko, Nikolay N. Klimko | | Clinical Microbiology and Antimicrobial Chemotherapy. 2021; 23(3): 255 | | [Pubmed] | [DOI] | | | 69 |
Nanomaterial-Based Antifungal Therapies to Combat Fungal Diseases Aspergillosis, Coccidioidomycosis, Mucormycosis, and Candidiasis |
|
| Angel León-Buitimea, Javier A. Garza-Cervantes, Diana Y. Gallegos-Alvarado, Macario Osorio-Concepción, José Ruben Morones-Ramírez | | Pathogens. 2021; 10(10): 1303 | | [Pubmed] | [DOI] | | | 70 |
Synthesis and Study of Antifungal Properties of New Cationic Beta-Glucan Derivatives |
|
| Kamil Kaminski, Magdalena Skora, Pawel Krzysciak, Sylwia Staczek, Agnieszka Zdybicka-Barabas, Malgorzata Cytrynska | | Pharmaceuticals. 2021; 14(9): 838 | | [Pubmed] | [DOI] | | | 71 |
Risk Factors for Fungal Co-Infections in Critically Ill COVID-19 Patients, with a Focus on Immunosuppressants |
|
| Obinna T. Ezeokoli, Onele Gcilitshana, Carolina H. Pohl | | Journal of Fungi. 2021; 7(7): 545 | | [Pubmed] | [DOI] | | | 72 |
COVID-19-Associated Mucormycosis (CAM): Case-Series and Global Analysis of Mortality Risk Factors |
|
| Abanoub Riad, Alshaimaa Ahmed Shabaan, Julien Issa, Sally Ibrahim, Hatem Amer, Yossef Mansy, Islam Kassem, Amira Bisher Kassem, Hans-Peter Howaldt, Miloslav Klugar, Sameh Attia | | Journal of Fungi. 2021; 7(10): 837 | | [Pubmed] | [DOI] | | | 73 |
Invasive Fungal Infections Complicating COVID-19: A Narrative Review |
|
| Giacomo Casalini, Andrea Giacomelli, Annalisa Ridolfo, Cristina Gervasoni, Spinello Antinori | | Journal of Fungi. 2021; 7(11): 921 | | [Pubmed] | [DOI] | | | 74 |
Novel Pathogenic Mucorales Identified Using the Silkworm Infection Model |
|
| Suresh Panthee, Hiroshi Hamamoto, Yayoi Nishiyama, Atmika Paudel, Kazuhisa Sekimizu | | Journal of Fungi. 2021; 7(11): 995 | | [Pubmed] | [DOI] | | | 75 |
Newer Horizon of Mesenchymal Stem Cell–Based Therapy in the Management of SARS-CoV-2–Associated Mucormycosis: A Safe Hope for Future Medicine |
|
| Alok Raghav, Syed Ghazanfar Ali, Goo-Bo Jeong, Kirti Amresh Gautam, Shahid Banday, Qazi Noorul Mateen, Prashant Tripathi, Richa Giri, Saurabh Agarwal, Manish Singh, Haris M. Khan | | Frontiers in Microbiology. 2021; 12 | | [Pubmed] | [DOI] | | | 76 |
Identifying Mucormycosis Severity in Indian COVID-19 Patients: A Nano-Based Diagnosis and the Necessity for Critical Therapeutic Intervention |
|
| Syed Mohammed Basheeruddin Asdaq, Arya Rajan, Aswin Damodaran, Shivali R. Kamath, Krishnanjana S. Nair, Subin Mary Zachariah, Ram Kumar Sahu, Santosh Fattepur, Nagaraja Sreeharsha, Anroop Nair, Shery Jacob, Hussain A. Albahrani, Eman H. Alkhaldi, Yahya Mohzari, Ahmed A. Alrashed, Mohd. Imran | | Antibiotics. 2021; 10(11): 1308 | | [Pubmed] | [DOI] | | | 77 |
COVID-19 Associated Mucormycosis: A Systematic Review from Diagnostic Challenges to Management |
|
| Farah Yasmin, Hala Najeeb, Aisha Naeem, Kartik Dapke, Rachana Phadke, Muhammad Sohaib Asghar, Syed Muhammad Ismail Shah, Domenico De Berardis, Irfan Ullah | | Diseases. 2021; 9(4): 65 | | [Pubmed] | [DOI] | | | 78 |
Mucormycosis in COVID-19: A systematic review of cases reported worldwide and in India |
|
| Awadhesh Kumar Singh, Ritu Singh, Shashank R. Joshi, Anoop Misra | | Diabetes & Metabolic Syndrome: Clinical Research & Reviews. 2021; 15(4): 102146 | | [Pubmed] | [DOI] | | | 79 |
Mucormycosis: An opportunistic pathogen during COVID-19 |
|
| Iyer Mahalaxmi, Kaavya Jayaramayya, Dhivya Venkatesan, Mohana Devi Subramaniam, Kaviyarasi Renu, Padmavathi Vijayakumar, Arul Narayanasamy, Abilash Valsala Gopalakrishnan, Nachimuthu Senthil Kumar, Palanisamy Sivaprakash, Krothapalli R.S. Sambasiva Rao, Balachandar Vellingiri | | Environmental Research. 2021; 201: 111643 | | [Pubmed] | [DOI] | | | 80 |
Mucormycosis coinfection in the context of global COVID-19 outbreak: A fatal addition to the pandemic spectrum |
|
| Popy Devnath, Kuldeep Dhama, Abu Montakim Tareq, Talha Bin Emran | | International Journal of Surgery. 2021; 92: 106031 | | [Pubmed] | [DOI] | | | 81 |
The surge in Covid related mucormycosis |
|
| Somesh Chandra, Rakesh Rawal | | Journal of Infection. 2021; 83(3): 381 | | [Pubmed] | [DOI] | | | 82 |
COVID-19 and mucormycosis superinfection: the perfect storm |
|
| Jaffar A. Al-Tawfiq, Saad Alhumaid, Abeer N. Alshukairi, Mohamad-Hani Temsah, Mazin Barry, Abbas Al Mutair, Ali A. Rabaan, Awadh Al-Omari, Raghavendra Tirupathi, Manaf AlQahtani, Salma AlBahrani, Kuldeep Dhama | | Infection. 2021; 49(5): 833 | | [Pubmed] | [DOI] | | | 83 |
Risk Based Decision Algorithms for Management of COVID-19 Associated Rhino-orbital Mucormycosis |
|
| Neeti Kapre Gupta, Madan Kapre, Harshkaran Gupta, Gauri Kapre Vaidya, Shripal Jani, Sonal Meshram, Sanjog Singh, Vidula Kapre, R. Ravi, Vilas Tambe, Nirmala Thakkar, Anju Mundhada | | Indian Journal of Otolaryngology and Head & Neck Surgery. 2021; | | [Pubmed] | [DOI] | | | 84 |
COVID-19, Diabetes and Steroids: The Demonic Trident for Mucormycosis |
|
| Sudhir Bhandari, Shruti Bhargava, Sunil Samdhani, Shashank Nath Singh, Bharat Bhushan Sharma, Sunita Agarwal, Man Prakash Sharma, Srikant Sharma, Vishnu Sharma, Shivankan Kakkar, Amitabh Dube, Mohnish Grover | | Indian Journal of Otolaryngology and Head & Neck Surgery. 2021; | | [Pubmed] | [DOI] | | | 85 |
Epidemiology and Pathophysiology of COVID-19-Associated Mucormycosis: India Versus the Rest of the World |
|
| Valliappan Muthu, Shivaprakash M. Rudramurthy, Arunaloke Chakrabarti, Ritesh Agarwal | | Mycopathologia. 2021; 186(6): 739 | | [Pubmed] | [DOI] | | | 86 |
IFN-? Mediated Signaling Improves Fungal Clearance in Experimental Pulmonary Mucormycosis |
|
| Amanda Ribeiro dos Santos, Thais Fernanda Fraga-Silva, Débora de Fátima Almeida-Donanzam, Rodolfo Ferreira dos Santos, Angela Carolina Finato, Cleverson Teixeira Soares, Vanessa Soares Lara, Nara Lígia Martins Almeida, Maria Izilda Andrade, Olavo Speranza de Arruda, Maria Sueli Parreira de Arruda, James Venturini | | Mycopathologia. 2021; | | [Pubmed] | [DOI] | | | 87 |
Post-COVID-19 rhino-orbito-cerebral mucormycosis: a new addition to challenges in pandemic control |
|
| Sandipta Mitra, Mridul Janweja, Arunabha Sengupta | | European Archives of Oto-Rhino-Laryngology. 2021; | | [Pubmed] | [DOI] | | | 88 |
Spectrum of fungal infections in COVID patients: The double whammy! |
|
| Mahima Lall, Kavita Bala Anand, Shelinder Pal Singh Shergill, Aditi Sondhi, Preeti Rai | | Medical Journal Armed Forces India. 2021; 77: S527 | | [Pubmed] | [DOI] | | | 89 |
Mucormycosis: A deadly black fungus infection among COVID-19 patients in India |
|
| Naveen Kumar Choudhary, Amit K. Jain, Rupesh Soni, Neha Gahlot | | Clinical Epidemiology and Global Health. 2021; 12: 100900 | | [Pubmed] | [DOI] | | | 90 |
Mucormycosis – An opportunistic infection in the aged immunocompromised individual: A reason for concern in COVID-19 |
|
| Vivek P. Chavda, Vasso Apostolopoulos | | Maturitas. 2021; 154: 58 | | [Pubmed] | [DOI] | | | 91 |
Intracranial Mucormycosis—A Minacious Foe |
|
| Sharad Pandey, Abrar Ahad Wani | | Indian Journal of Neurosurgery. 2021; 10(02): 092 | | [Pubmed] | [DOI] | | | 92 |
COVID-19 associated mucormycosis: the urgent need to reconsider the indiscriminate use of immunosuppressive drugs |
|
| Alfonso J. Rodriguez-Morales, Ranjit Sah, Jose Millan-Oñate, Angel Gonzalez, Juan J. Montenegro-Idrogo, Sias Scherger, Carlos Franco-Paredes, Andrés F. Henao-Martínez | | Therapeutic Advances in Infectious Disease. 2021; 8: 2049936121 | | [Pubmed] | [DOI] | | | 93 |
A case report of rhino-facial mucormycosis in a non-diabetic patient with COVID-19: a systematic review of literature and current update |
|
| Faezeh Mohammadi, Milad Badri, Shapoor Safari, Nima Hemmat | | BMC Infectious Diseases. 2021; 21(1) | | [Pubmed] | [DOI] | | | 94 |
COVID-19-associated mucormycosis: Case report and systematic review |
|
| Ahmet Dilek, Resat Ozaras, Sevket Ozkaya, Mustafa Sunbul, Elif Itir Sen, Hakan Leblebicioglu | | Travel Medicine and Infectious Disease. 2021; 44: 102148 | | [Pubmed] | [DOI] | | | 95 |
Pathogenesis of Respiratory Viral and Fungal Coinfections |
|
| Fabián Salazar, Elaine Bignell, Gordon D. Brown, Peter C. Cook, Adilia Warris | | Clinical Microbiology Reviews. 2021; | | [Pubmed] | [DOI] | | | 96 |
Epidemiology and Antifungal Susceptibilities of Mucoralean Fungi in Clinical Samples from the United States |
|
| Hamid Badali, Connie Cañete-Gibas, Dora McCarthy, Hoja Patterson, Carmita Sanders, Marjorie P. David, James Mele, Hongxin Fan, Nathan P. Wiederhold, Kimberly E. Hanson | | Journal of Clinical Microbiology. 2021; 59(9) | | [Pubmed] | [DOI] | | | 97 |
CT Findings of COVID-19–associated Pulmonary Mucormycosis: A Case Series and Literature Review |
|
| Mandeep Garg, Nidhi Prabhakar, Valliappan Muthu, Shameema Farookh, Harsimran Kaur, Vikas Suri, Ritesh Agarwal | | Radiology. 2021; : 211583 | | [Pubmed] | [DOI] | | | 98 |
An epidemic within a pandemic |
|
| Niladri Banerjee, Anannya Ray Banerjee, Harshita Agarwal, Harshit Agarwal | | Tropical Doctor. 2021; : 0049475521 | | [Pubmed] | [DOI] | | | 99 |
Mucormycosis in patients with COVID-19: A cross-sectional descriptive multicentre study from Iran |
|
| Farzad Pakdel, Kazem Ahmadikia, Mohammadreza Salehi, Azin Tabari, Rozita Jafari, Golfam Mehrparvar, Yasaman Rezaie, Shahin Rajaeih, Neda Alijani, Aleksandra Barac, Alireza Abdollahi, Sadegh Khodavaisy | | Mycoses. 2021; 64(10): 1238 | | [Pubmed] | [DOI] | | | 100 |
COVID-19-associated mucormycosis: An updated systematic review of literature |
|
| Rimesh Pal, Birgurman Singh, Sanjay Kumar Bhadada, Mainak Banerjee, Ranjitpal Singh Bhogal, Neemu Hage, Ashok Kumar | | Mycoses. 2021; 64(12): 1452 | | [Pubmed] | [DOI] | | | 101 |
Mucormycosis and COVID-19: An epidemic within a pandemic in India |
|
| Lav Selarka, Suktara Sharma, Dinesh Saini, Sanjay Sharma, Amit Batra, Vishal T. Waghmare, Pratibha Dileep, Sanket Patel, Monarch Shah, Tejas Parikh, Prakash Darji, Amit Patel, Gaurav Goswami, Anand Shah, Sandeep Shah, Harsh Lathiya, Moksha Shah, Pranita Sharma, Surabhi Chopra, Ankur Gupta, Neha Jain, Erum Khan, Vijay K. Sharma, Arvind K. Sharma, Amanda C. Y. Chan, Jonathan J. Y. Ong | | Mycoses. 2021; 64(10): 1253 | | [Pubmed] | [DOI] | | | 102 |
Emerging Fungal Infections: New Species, New Names, and Antifungal Resistance |
|
| Nathan P Wiederhold | | Clinical Chemistry. 2021; 68(1): 83 | | [Pubmed] | [DOI] | | | 103 |
Clinical Presentations, Management and Outcomes of Rhino-Orbital-Cerebral Mucormycosis (ROCM) Following COVID-19: A Multi-Centric Study |
|
| Tarjani Vivek Dave, Akshay Gopinathan Nair, Raghuraj Hegde, Nidhi Vithalani, Savari Desai, Namrata Adulkar, Saurabh Kamal, Raman Mittal, Renuka A. Bradoo | | Ophthalmic Plastic & Reconstructive Surgery. 2021; 37(5): 488 | | [Pubmed] | [DOI] | | | 104 |
Impact of COVID-19-associated Mucormycosis in Kidney Transplant Recipients: A Multicenter Cohort Study. |
|
| Hari Shankar Meshram, Vivek B. Kute, Dinesh Kumar Yadav, Suraj Godara, Sonal Dalal, Sandeep Guleria, Anil K. Bhalla, Vivek Pathak, Urmila Anandh, Shyam Bansal, Himanshu Patel, Umapati Hegde, Ruchir Dave, Sanshriti Chauhan, Rutul Dave, Deepak Kumar, Tukaram Jamale, Divya Bajpai, Deepesh Kenwar, Keshab Sil, Harsh Vardhan, Manish Balwani, Mayur Patil, Rushi Deshpande, Ashish Nandwani, Pranaw Kumar Jha, Manish Jain, Pratik Das, Vineet Mishra, Dorry L. Segev, Vijay Kher | | Transplantation Direct. 2021; 8(1): e1255 | | [Pubmed] | [DOI] | | | 105 |
Rhino-orbital COVID-19 associated mucormycosis- A case report |
|
| Shanmuga Vadivoo Natarajan, B Usha | | IP International Journal of Medical Microbiology and Tropical Diseases. 2021; 7(4): 304 | | [Pubmed] | [DOI] | | | 106 |
Concurrent and Post COVID-19 Ophthalmological Implications |
|
| Tamer EE Wasfy, Mohamed A Eldesouky, Yasser Serag, Hazem A Elbedewy | | Clinical Ophthalmology. 2021; Volume 15: 4467 | | [Pubmed] | [DOI] | | | 107 |
A multicentric observational study of imaging findings in COVID-19-related rhino-orbito-cerebral mucormycosis: a new Pandora’s box |
|
| Annu Singhal, Shikha Jain, Swati Sharma, Vivek Cherumanalil Kottiyath, Girish Khandelwal | | Egyptian Journal of Radiology and Nuclear Medicine. 2021; 52(1) | | [Pubmed] | [DOI] | | | 108 |
COVID-19–associated mucormycosis: Evidence-based critical review of an emerging infection burden during the pandemic’s second wave in India |
|
| Jesil Mathew Aranjani, Atulya Manuel, Habeeb Ibrahim Abdul Razack, Sam T. Mathew, Susanna Kar Pui Lau | | PLOS Neglected Tropical Diseases. 2021; 15(11): e0009921 | | [Pubmed] | [DOI] | | | 109 |
Spike in Rhino-Orbital-Cerebral Mucormycosis Cases Presenting to a Tertiary Care Center During the COVID-19 Pandemic |
|
| Yousef A. Fouad, Tougan Taha Abdelaziz, Anas Askoura, Mohamed Ibrahim Saleh, Mohammad S. Mahmoud, Doaa Maamoun Ashour, Manar Maamoun Ashour | | Frontiers in Medicine. 2021; 8 | | [Pubmed] | [DOI] | |
|
 |
|
|
|
.png "Santen")
Search Pubmed for